BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9156414)

  • 1. Efficacy and safety of low molecular weight heparin in patients with mechanical heart valves: systematic review and meta-analysis.
    Caldeira D; David C; Santos AT; Costa J; Pinto FJ; Ferreira JJ
    J Thromb Haemost; 2014 May; 12(5):650-9. PubMed ID: 24593838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial indications for the low molecular weight heparins.
    Ageno W; Huisman MV
    Curr Control Trials Cardiovasc Med; 2001; 2(5):233-239. PubMed ID: 11806802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring the appropriate prescription of low molecular weight heparins and Fondaparinux through administrative data. A retrospective observational study in the Tuscany region.
    Moretti G; Vinci B; Zito S; Caputo A; Attanasio F; Vainieri M
    PLoS One; 2023; 18(9):e0291628. PubMed ID: 37708187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of experimentally induced caval thrombosis with oral low molecular weight heparin and delivery agent in a porcine model of deep venous thrombosis.
    Salartash K; Lepore M; Gonze MD; Leone-Bay A; Baughman R; Sternbergh WC; Bowen JC; Money SR
    Ann Surg; 2000 Jun; 231(6):789-94. PubMed ID: 10816621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparin in the treatment of deep venous thrombosis.
    Hauer KE
    West J Med; 1998 Oct; 169(4):240-4. PubMed ID: 9795594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group.
    van den Belt AG; Bossuyt PM; Prins MH; Gallus AS; Büller HR
    Thromb Haemost; 1998 Feb; 79(2):259-63. PubMed ID: 9493572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-molecular-weight heparin for the out-of-hospital treatment of venous thrombosis: rationale and clinical results.
    Crowther M; Hirsh J
    Semin Thromb Hemost; 1997; 23(1):77-81. PubMed ID: 9156414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight heparin for the out-of-hospital treatment of venous thrombosis: rationale and clinical results.
    Hirsh J; Crowther M
    Thromb Haemost; 1997 Jul; 78(1):689-92. PubMed ID: 9198240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG
    Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.